CN101966290A - Medicament for treating neurasthenia and preparation method thereof - Google Patents

Medicament for treating neurasthenia and preparation method thereof Download PDF

Info

Publication number
CN101966290A
CN101966290A CN2010102954641A CN201010295464A CN101966290A CN 101966290 A CN101966290 A CN 101966290A CN 2010102954641 A CN2010102954641 A CN 2010102954641A CN 201010295464 A CN201010295464 A CN 201010295464A CN 101966290 A CN101966290 A CN 101966290A
Authority
CN
China
Prior art keywords
radix
medicine
parched
rhizoma
neurasthenia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010102954641A
Other languages
Chinese (zh)
Inventor
申东升
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010102954641A priority Critical patent/CN101966290A/en
Publication of CN101966290A publication Critical patent/CN101966290A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicament for treating neurasthenia, which is prepared by the following steps of: adding water to decoct Chinese angelica, szechwan lovage rhizome, raw white paeony root, the dried rhizome of rehmannia, mother of pearl, fried jujube seed, platycladi seed, fried bighead atractylodes rhizome, fragrant solomonseal rhizome, fructus schisandrae, common macrocarpium fruit, medlar and liquorice twice, 2 to 4 hours each time, concentrating decoction into cream with the temperature of 50 DEG C and the relative density of 1.04 to 1.05, drying under reduced pressure, crushing into fine powder, and uniformly mixing to obtain a capsule product. The medicament has the effects of nourishing liver and kidney, dispersing stagnated liver qi for relieving qi stagnation, nourishing spleen and regulating qi, enriching blood to nourish the heart, and tranquilizing mind, treats the neurasthenia based on syndrome differentiation from holistic approach, treats the principal aspect quickly and the secondary aspect slowly, has exact curative effect for treating the neurasthenia, and has the effective rate of 92.8 percent through clinical observation.

Description

Neurasthenic medicine of a kind of treatment and preparation method thereof
Technical field
The present invention relates to the neurasthenic medicine of a kind of treatment, particularly relating to a kind of is the neurasthenic medicine of treatment of crude drug preparation with Chinese medicine, and the preparation method of this medicine.
Background technology
The neurasthenia is a kind of spirituality obstacle, because people's cerebral cortex is in excited for a long time and suppresses irregular state, causes patient's cerebral vasospasm, and cerebral blood flow reduces, the cerebral oxygen supply deficiency, and function of brain cell goes down.Clinical manifestation is that patient daytime is often sleepy, sleepy, weak, drowsiness, then has a sleepless night night, dreaminess, has lost normal person's excitement and inhibition temporal regularity.Studies show that work, study hypertonicity are acted hurriedly in a messy situation, it is irregular to have a rest and sleep, and operating pressure is big, and health is in subhealth state, and feels to have burden and unhappy emotion etc., is to cause neurasthenic main cause.
The western medical treatment neurasthenia mainly relies on to stabilize and waits the tranquilizer symptomatic treatment of sleeping peacefully at present, but there is defective in these medicines aspect safety and the dependency, and side effect is bigger, forms addiction and drug resistance easily, so should not take for a long time.
Summary of the invention
It is little to the purpose of this invention is to provide a kind of toxic and side effects, and outstanding effect is treated neurasthenic Chinese medicine medicine.
Medicine of the present invention is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Radix Angelicae Sinensis 10~15 Rhizoma Chuanxiongs 15~20 Radix Paeoniae Alba 15~20
The Radix Rehmanniae 15~20 Concha Margaritiferas 30~40 Semen Ziziphi Spinosae (parched)s 15~20
Semen Platycladi 10~20 Rhizoma Atractylodis Macrocephalae (parched)s 5~10 Rhizoma Polygonati Odorati 5~10
Fructus Schisandrae Chinensis 10~15 mountain cornels 20~25 Fructus Lycii 20~25
Radix Glycyrrhizae 3~5.
Said medicine can be made any peroral dosage form on the pharmaceutics, as tablet, pill, watered pill, powder, capsule etc., the preferred dosage form of the present invention is a capsule.
The concrete preparation method of above-mentioned each crude drug being made medicine of the present invention is:
Getting Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae Alba, the Radix Rehmanniae, Concha Margaritifera, Semen Ziziphi Spinosae (parched), Semen Platycladi, Rhizoma Atractylodis Macrocephalae (parched), Rhizoma Polygonati Odorati, Fructus Schisandrae Chinensis, mountain cornel, Fructus Lycii, Radix Glycyrrhizae by above-mentioned parts by weight decocts with water 2 times, each amount of water is 3~4 times of crude drug gross weight, decoct 2~4h, collecting decoction filters, concentrate the clear paste of 50 ℃ of relative densities 1.04~1.05, drying under reduced pressure is ground into fine powder, mixing, encapsulated, promptly.
Usage: the adult takes 2 at every turn, and is every day 2 times, oral.
Motherland's medical science thinks that the neurasthenia belongs to scopes such as " being insomnia ", " cardiopalmus ", " strongly fragrant disease ", " deficient ", " seminal emission ", " sexual impotence ", how to be hindered by feelings will, and spiritual hypertonicity, or after the serious disease prolonged illness due to the visceral dysfunction.If disgruntled smooth, depression and stagnation of QI, gas lose catharsis and then cause depression of liver-QI; Work with one's mind and think become homeless foster, dysfunction of the spleen in transportation, source of generating QI and blood deficiency of void, the stagnation of liver-QI impairment of the spleen, insufficiency of the spleen insufficiency of blood, the heart and then cause deficiency of both the heart and spleen; Stagnation of liver-QI with the passing of time, fire-transformation impairment of YIN, deficiency of kidney yin, the kidney failing to nourish the liver, the liver imbalance is supported and is then caused the hepatic and renal YIN deficiency; Deficiency of the kidney or excess of sexual intercourse, injure kidney yang, smart close solid, decline of the fire from the gate of life and then cause insufficiency of kidney-YANG.In the prescription of the present invention, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae Alba blood circulation promoting and blood stasis dispelling, nourishing blood for regulating menstruation; Radix Rehmanniae clearing away heat and cooling blood, YIN nourishing and the production of body fluid promoting, blood circulation promoting and blood stasis dispelling; Concha Margaritifera, Semen Ziziphi Spinosae (parched), Semen Platycladi, mountain cornel, Fructus Lycii mind tranquilizing and the heart calming, promoting the production of body fluid to quench thirst, strong muscle kidney tonifying, reinforcing the heart is enriched blood, tranquillizing the mind by relieving convulsion; The Radix Glycyrrhizae invigorating the spleen and replenishing QI, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.All medicine compatibilities, nourishing the liver and kidney, soothing liver-QI for relieving depression, spleen invigorating are regulated the flow of vital energy, replenishing blood for nourishing heart, sedate are calmed the nerves, and carry out determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs from the integral body sight, symptomatic treatment in acute condition, relieving the primary symptom in a chronic case, treatment neurasthenia determined curative effect.
Medicine patient of the present invention is easy to take, and takes safety, can reduce complication and take place, and clinical effectiveness is good, and easy to use, and price is suitable.
For further investigating the clinical efficacy and the safety of medicine of the present invention, select 500 routine neurasthenias that the curative effect of medicine of the present invention is carried out clinical observation.
500 routine cases are divided into two groups at random, every group 250 example.Male 123 examples in the matched group, women 127 examples; 17~54 years old age, average 48.3 years old; The course of disease 1~55 month, average 4.9 months.Male 128 examples in the treatment group, women 122 examples; 18~43 years old age, average 47.3 years old; Course of disease 15d~25 month, average 3.8 months.Two groups of cases at aspects such as sex, age, the courses of disease by statistics credit analyse the difference not statistically significant.The diagnosis of all cases is diagnosed with reference to neurasthenic diagnostic criteria in " neurological ", and meets diagnostic criteria.
Therapeutic Method: matched group is urged brain cell metabolism and psychotherapy with alprazolam anxiety, vitamin B group trophic nerve, citicoline.The treatment group gives medicine of the present invention, and each 2, every day 2 times, oral meal.
Curative effect determinate standard: recovery from illness: clinical symptom disappearance does not influence operate as normal study; Produce effects: sleep quality improves, and appetite increases, and symptoms such as headache, dizziness, fatigue and weak take a turn for the better, and memory increases; Effectively: above-mentioned symptom makes moderate progress; Invalid: treatment back clinical symptoms no change.
Curative effect comparative result after two groups of cases are treated sees Table 1.
Table 1 liang group case treatment back curative effect relatively
Figure BSA00000287860000021
The specific embodiment
Embodiment 1
Medicine is chosen most impurity, screening dry in the sun, after the oven dry, take by weighing Radix Angelicae Sinensis 10Kg, Rhizoma Chuanxiong 15Kg, Radix Paeoniae Alba 15Kg, Radix Rehmanniae 15Kg, Concha Margaritifera 30Kg, Semen Ziziphi Spinosae (parched) 15Kg, Semen Platycladi 10Kg, Rhizoma Atractylodis Macrocephalae (parched) 5Kg, Rhizoma Polygonati Odorati 5Kg, Fructus Schisandrae Chinensis 10Kg, mountain cornel 20Kg, Fructus Lycii 20Kg, Radix Glycyrrhizae 3Kg, add 3 times to the water of medical material weight, decoct 4h, leach decocting liquid, the decocting that adds 3 times of weight of medical material again boils 3h, leaches decocting liquid, collecting decoction, filter, be concentrated into the clear paste of 50 ℃ of relative densities 1.05, drying under reduced pressure, be ground into fine powder, mixing, encapsulated, promptly.Usage: the adult takes 2 at every turn, and is every day 2 times, oral.
Embodiment 2
Medicine is chosen most impurity, screening dry in the sun, after the oven dry, take by weighing Radix Angelicae Sinensis 12Kg, Rhizoma Chuanxiong 16Kg, Radix Paeoniae Alba 18Kg, Radix Rehmanniae 18Kg, Concha Margaritifera 32Kg, Semen Ziziphi Spinosae (parched) 18Kg, Semen Platycladi 12Kg, Rhizoma Atractylodis Macrocephalae (parched) 8Kg, Rhizoma Polygonati Odorati 8Kg, Fructus Schisandrae Chinensis 12Kg, mountain cornel 22Kg, Fructus Lycii 22Kg, Radix Glycyrrhizae 5Kg, add 3 times to the water of medical material weight, decoct 4h, leach decocting liquid, the decocting that adds 3 times of weight of medical material again boils 3h, leaches decocting liquid, collecting decoction, filter, be concentrated into the clear paste of 50 ℃ of relative densities 1.05, drying under reduced pressure, be ground into fine powder, mixing, encapsulated, promptly.

Claims (3)

1. neurasthenic medicine of treatment is that crude drug prepares by the Chinese medicine of following portions by weight:
Radix Angelicae Sinensis 10~15 Rhizoma Chuanxiongs 15~20 Radix Paeoniae Alba 15~20
The Radix Rehmanniae 15~20 Concha Margaritiferas 30~40 Semen Ziziphi Spinosae (parched)s 15~20
Semen Platycladi 10~20 Rhizoma Atractylodis Macrocephalae (parched)s 5~10 Rhizoma Polygonati Odorati 5~10
Fructus Schisandrae Chinensis 10~15 mountain cornels 20~25 Fructus Lycii 20~25
Radix Glycyrrhizae 3~5.
2. the neurasthenic medicine of treatment according to claim 1 is characterized in that described medicine is made capsule.
3. the preparation method of the neurasthenic medicine of the described treatment of claim 2, it is characterized in that according to described parts by weight, getting Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae Alba, the Radix Rehmanniae, Concha Margaritifera, Semen Ziziphi Spinosae (parched), Semen Platycladi, Rhizoma Atractylodis Macrocephalae (parched), Rhizoma Polygonati Odorati, Fructus Schisandrae Chinensis, mountain cornel, Fructus Lycii, Radix Glycyrrhizae decocts with water 2 times, each amount of water is 3~4 times of crude drug gross weight, decoct 2~4h, collecting decoction, filter, be concentrated into the clear paste of 50 ℃ of relative densities 1.04~1.05, drying under reduced pressure is ground into fine powder, mixing, encapsulated, promptly.
CN2010102954641A 2010-09-29 2010-09-29 Medicament for treating neurasthenia and preparation method thereof Pending CN101966290A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010102954641A CN101966290A (en) 2010-09-29 2010-09-29 Medicament for treating neurasthenia and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010102954641A CN101966290A (en) 2010-09-29 2010-09-29 Medicament for treating neurasthenia and preparation method thereof

Publications (1)

Publication Number Publication Date
CN101966290A true CN101966290A (en) 2011-02-09

Family

ID=43545552

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010102954641A Pending CN101966290A (en) 2010-09-29 2010-09-29 Medicament for treating neurasthenia and preparation method thereof

Country Status (1)

Country Link
CN (1) CN101966290A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102949663A (en) * 2012-11-03 2013-03-06 陶素爱 Traditional Chinese medicinal composite for treating vegetative nerve functional disturbance
CN103006885A (en) * 2012-12-26 2013-04-03 青岛佰众化工技术有限公司 Chinese medicinal composition for treating qi-stagnancy and blood stasis type psychogeny
CN103110743A (en) * 2013-03-08 2013-05-22 崔合芳 Traditional Chinese medicine composition for treating or preventing neurasthenia and preparation method thereof
CN103372144A (en) * 2012-04-28 2013-10-30 宋艳洁 Traditional Chinese medicine preparation for treating neurasthenia and preparation method thereof
CN103599363A (en) * 2013-11-29 2014-02-26 青岛中科菲力工程技术研发有限公司 Traditional Chinese medicine combination for treating neurasthenia
CN103654030A (en) * 2013-11-29 2014-03-26 杨明志 Medicinal pillow with neurasthenia treatment effect
CN105287994A (en) * 2014-05-29 2016-02-03 李益坤 Medicine for treating neurasthenia

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1663602A (en) * 2003-12-31 2005-09-07 赵恒� Medicine for treating neurasthenia
CN101450122A (en) * 2008-12-30 2009-06-10 南京中医药大学 Traditional Chinese medicine preparation for treating insomnia and preparation method and use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1663602A (en) * 2003-12-31 2005-09-07 赵恒� Medicine for treating neurasthenia
CN101450122A (en) * 2008-12-30 2009-06-10 南京中医药大学 Traditional Chinese medicine preparation for treating insomnia and preparation method and use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
《山西中医学院学报》 20091231 张军等 中西医结合治疗神经衰弱68例疗效观察 第34-35页 1-3 第10卷, 第5期 2 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103372144A (en) * 2012-04-28 2013-10-30 宋艳洁 Traditional Chinese medicine preparation for treating neurasthenia and preparation method thereof
CN103372144B (en) * 2012-04-28 2016-01-20 宋艳洁 One treats neurasthenic Chinese medicine preparation and preparation method
CN102949663A (en) * 2012-11-03 2013-03-06 陶素爱 Traditional Chinese medicinal composite for treating vegetative nerve functional disturbance
CN103006885A (en) * 2012-12-26 2013-04-03 青岛佰众化工技术有限公司 Chinese medicinal composition for treating qi-stagnancy and blood stasis type psychogeny
CN103110743A (en) * 2013-03-08 2013-05-22 崔合芳 Traditional Chinese medicine composition for treating or preventing neurasthenia and preparation method thereof
CN103599363A (en) * 2013-11-29 2014-02-26 青岛中科菲力工程技术研发有限公司 Traditional Chinese medicine combination for treating neurasthenia
CN103654030A (en) * 2013-11-29 2014-03-26 杨明志 Medicinal pillow with neurasthenia treatment effect
CN105287994A (en) * 2014-05-29 2016-02-03 李益坤 Medicine for treating neurasthenia

Similar Documents

Publication Publication Date Title
CN101966290A (en) Medicament for treating neurasthenia and preparation method thereof
CN102526474A (en) Chinese medicine composition for treating neurasthenia
CN104873745A (en) Traditional Chinese medicine composition for treating insomnia and preparation method
CN103041027B (en) Traditional Chinese medicine for treating liver depression forming fire syndrome type insomnia
CN102861228A (en) Traditional Chinese medicine composition for treating insomnia
CN103599496B (en) Traditional Chinese medicine for treatment of chronic gastritis
CN103127472B (en) Traditional Chinese medicine compound for refractory insomnia
CN103055045B (en) Traditional Chinese medical preparation for treating hypotension
CN107349411A (en) Chinese medicine composition for treating irregular menstruation and preparation method thereof
CN103977217A (en) Medicinal composition for treating renal carcinoma
CN103405636A (en) Drug for treating insomnia and preparation method thereof
CN102512633A (en) Traditional Chinese medicinal composition for treating insomnia
CN104547532A (en) Traditional Chinese medicine preparation for treating migraine and preparation method of traditional Chinese medicine preparation
CN106492018A (en) A kind of Chinese medicine composition for treating insomnia and preparation method thereof
CN106214916A (en) A kind of for medicine treating perimenopausal syndrome and preparation method thereof
CN102366527A (en) Traditional Chinese medicine formula for treating vitiligo
CN103041019A (en) Traditional Chinese medicine composition for treating delayed menorrhea
CN104888136A (en) Traditional Chinese medicine composition for treatment of insomnia
CN101543611B (en) Traditional Chinese medicine for treating hysteria
CN104800799A (en) Traditional Chinese medicament for treating endometrial thickening with ovarian cysts
CN101703660B (en) Anti-aging medicament
CN105232999A (en) Traditional Chinese medicine composition for tonifying qi, activating blood and controlling nocturnal emission
CN104547556A (en) Traditional Chinese medicine preparation for treating pediatric epilepsy and preparation method thereof
CN103705733A (en) Chinese medicine capsule for treating arrhythmia and preparation method thereof
CN104056230A (en) Traditional Chinese medicinal composition for treating heart-spleen deficiency type insomnia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20110209